The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial

<p><strong>Introduction</strong> Symptoms reported following the administration of investigational drugs play an important role in decisions for registration and treatment guidelines. However, symptoms are subjective, and interview methods to quantify them are difficult to standard...

Descripció completa

Dades bibliogràfiques
Autors principals:	Thriemer, K, Commons, RJ, Rajasekhar, M, Degaga, TS, Chand, K, Chau, NH, Assefa, A, Naddim, MN, Pasaribu, AP, Rahim, AG, Sutanto, I, Hien, TT, Hailu, A, Hasanzai, MA, Ekawati, LL, Woyessa, A, Teferi, T, Waithira, N, Taylor, WRJ, Ley, B, Dondorp, A, Baird, JK, White, NJ, Day, NP, Price, RN, Simpson, JA, von Seidlein, L
Format:	Journal article
Idioma:	English
Publicat:	BioMed Central 2023

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial

Ítems similars